Search
![](https://static.wixstatic.com/media/nsplsh_cdc07c343c5841689f17d4d2a8220bcc~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/nsplsh_cdc07c343c5841689f17d4d2a8220bcc~mv2.jpg)
![USFDA Guidance - Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production](https://static.wixstatic.com/media/nsplsh_cdc07c343c5841689f17d4d2a8220bcc~mv2.jpg/v1/fill/w_399,h_300,fp_0.50_0.50,q_90,enc_auto/nsplsh_cdc07c343c5841689f17d4d2a8220bcc~mv2.jpg)
Sharan Murugan
- May 17, 2022
- 1 min
USFDA Guidance - Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production
USFDA is announcing revisions to the 2006 guidance “Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production"....
87 views0 comments
![](https://static.wixstatic.com/media/nsplsh_2b96a2bbc8b6400ab7ad5c9be6f459f0~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/nsplsh_2b96a2bbc8b6400ab7ad5c9be6f459f0~mv2.jpg)
![USFDA Guidance on Product Quality Assessments - Benefit-Risk Considerations](https://static.wixstatic.com/media/nsplsh_2b96a2bbc8b6400ab7ad5c9be6f459f0~mv2.jpg/v1/fill/w_399,h_300,fp_0.50_0.50,q_90,enc_auto/nsplsh_2b96a2bbc8b6400ab7ad5c9be6f459f0~mv2.jpg)
Sharan Murugan
- May 11, 2022
- 1 min
USFDA Guidance on Product Quality Assessments - Benefit-Risk Considerations
Earlier on 9-May-2022, FDA announced that a draft guidance document was available to assist the industry regarding the Benefit-Risk...
25 views0 comments